On April 14, U.S. District Judge Matthew F. Kennelly ruled, in relevant part, that the U.S. Department of Labor (DOL) cannot require federal grant recipients to certify that their diversity, equity and inclusion (DEI) programs do not violate applicable federal anti-discrimination law and prohibited the termination of the plaintiff’s Women in Apprenticeship and Nontraditional Occupations (WANTO) grant on the basis that it was “equity-related.”
Key Takeaways from DOJ’s Continued Cybersecurity Enforcement
On March 25, the U.S. Department of Justice (DOJ) announced a $4.6 million settlement with MORSECORP, Inc. (MORSE) over its alleged failures to satisfy cybersecurity requirements for federal defense contractors.
Continue Reading Key Takeaways from DOJ’s Continued Cybersecurity EnforcementFalse Claims Act Gives Broad Dismissal Authority to Government, District Judge Says
On April 2, the United States District Court for the Eastern District of Virginia dismissed a whistleblower’s False Claims Act (FCA) action after the relator attempted to dismiss the government as a plaintiff-intervenor in the lawsuit.
Continue reading on the GovCon & Trade blog.
New False Claims Act Settlement Highlights Importance of Voluntary Self-Disclosures and Due Diligence
According to an April 1 Department of Justice (DOJ) press release, DRI Relays Inc. (DRI), a subsidiary of TE Connectivity Corporation (TEC) and manufacturer of electrical relays and sockets used on military platforms, agreed to pay $15.7 million to settle allegations that it violated the False Claims Act (FCA).
Continue Reading on the GovCon & Trade blog
Potential Shift in Healthcare Fraud Oversight
I recently provided insight about the potential shift in healthcare fraud oversight amid federal changes and several recent cases that could narrow the scope of investigations and ultimately lower costs that health systems spend to fight fraud allegations.
Continue Reading Potential Shift in Healthcare Fraud OversightDOJ Settlement Highlights Customs, FCA Risks for Importers
On March 25, 2025, the U.S. Department of Justice (DOJ) announced an $8.1 million settlement in a civil case under the False Claims Act (FCA) related to alleged customs evasion by a California importer of wood flooring. The private whistleblower who reported the conduct received over $1.2 million in the matter. As we suggested in a blog post in February, these sorts of enforcement actions will proliferate under the Trump DOJ.
Continue Reading on the GovCon & Trade blog
Seoul Medical Group and Renaissance Imaging Medical Associates Settle Medicare Risk Adjustment Fraud Case for $62 Million
The Department of Justice announced this week that California-based primary care provider Seoul Medical Group, Inc. (SMG), SMG’s former president and majority owner, and California-based radiology group Renaissance Imaging Medical Associates Inc. (Renaissance) will pay a combined $62.85 million to resolve allegations of False Claims Act violations related to the submission of unsupported diagnosis codes to Medicare Advantage Organizations in order to increase reimbursement from the government.
Continue Reading Seoul Medical Group and Renaissance Imaging Medical Associates Settle Medicare Risk Adjustment Fraud Case for $62 MillionFalse Claims Act Enforcement in Healthcare: Insights from the 13th Annual Fraud & Abuse Review
The False Claims Act (FCA) remains one of the government’s most powerful tools in combating healthcare fraud, with a growing focus on opioid-related cases and violations of the Anti-Kickback Statute.
Continue Reading False Claims Act Enforcement in Healthcare: Insights from the 13th Annual Fraud & Abuse ReviewDownload Now – 13th Annual Healthcare Fraud & Abuse Review
Our 13th annual Healthcare Fraud & Abuse Review, compiled by the Bass, Berry & Sims Healthcare Fraud & Abuse Task Force, is now available, providing an in-depth look at the key enforcement trends, legal decisions, and settlements shaping the healthcare industry in 2024.
Continue Reading Download Now – 13th Annual Healthcare Fraud & Abuse ReviewRegister Now | Healthcare Fraud & Abuse Annual Review Webinar
Bass, Berry & Sims will release its 13th Annual Healthcare Fraud & Abuse Review the first week of March. As a companion to the Review, we will host a complimentary webinar on Thursday, March 20 from 11:00 a.m. – 1:00 p.m. CT, which will provide an overview and discussion of key focus areas covered in the Review.
Continue Reading Register Now | Healthcare Fraud & Abuse Annual Review Webinar